Resultats de la cerca - Kazuhiro Ohara
- Mostrar 1 - 3 resultats de 3
-
1
Disruption of CRAF-Mediated MEK Activation Is Required for Effective MEK Inhibition in KRAS Mutant Tumors per Piro Lito, Anna Saborowski, Jingyin Yue, Martha Solomon, Eric W. Joseph, Sunyana Gadal, Michael Saborowski, Edward R. Kastenhuber, Christof Fellmann, Kazuhiro Ohara, Kenji Morikami, Takaaki Miura, Christine Lukacs, Nobuya Ishii, Scott W. Lowe, Neal Rosen
Publicat 2014Artigo -
2
Enhanced Inhibition of ERK Signaling by a Novel Allosteric MEK Inhibitor, CH5126766, That Suppresses Feedback Reactivation of RAF Activity per Nobuya Ishii, Naoki Harada, Eric W. Joseph, Kazuhiro Ohara, Takaaki Miura, Hiroshi Sakamoto, Yutaka Matsuda, Yasushi Tomii, Yukako Tachibana-Kondo, Hitoshi Iikura, Toshihiro Aoki, Nobuo Shimma, Mikio Arisawa, Yoshihiro Sowa, Poulikos I. Poulikakos, Neal Rosen, Yuko Aoki, Toshiyuki Sakai
Publicat 2013Artigo -
3
Exploitation of Elevated Extracellular ATP to Specifically Direct Antibody to Tumor Microenvironment per Futa Mimoto, K. Tatsumi, Shun Shimizu, Shojiro Kadono, Kenta Haraya, Miho Nagayasu, Yuki Suzuki, Etsuko Fujii, Masaki Kamimura, Akira Hayasaka, Hiroki Kawauchi, Kazuhiro Ohara, Masayuki Matsushita, Takeshi Baba, Hiroaki Susumu, Takuya Sakashita, Terushige Muraoka, Kosuke Aso, Hitoshi Katada, Eriko Tanaka, Kenji Nakagawa, Masami Hasegawa, Miho Ayabe, Tessai Yamamoto, Shigero Tanba, Takahiro Ishiguro, Takayuki Kamikawa, Takeru Nambu, Tatsuya Kibayashi, Yumiko Azuma, Yasushi Tomii, Atsuhiko Kato, Kazuhisa Ozeki, Naoaki Murao, Mika Endo, Junichi Kikuta, Mika Kamata‐Sakurai, Masaru Ishii, Kunihiro Hattori, Tomoyuki Igawa
Publicat 2020Artigo
Eines de cerca:
Matèries relacionades
Biochemistry
Biology
Cancer research
Cell biology
Chemistry
MAPK/ERK pathway
MEK inhibitor
Phosphorylation
Adenosine triphosphate
Allosteric regulation
Antibody
Antigen
Cell culture
Extracellular
Gene
Gene knockdown
Genetics
Immunology
KRAS
Kinase
Melanoma
Molecular biology
Mutant
Mutation
Protein kinase A
Receptor
Selumetinib
Signal transduction
Trametinib
Tumor cells